Rituximab in CD20 positive multiple myeloma

被引：0
|
作者：
J M Bergua
C Cabrera
E G Arteta
J Prieto
机构：
[1] Servicio de Hematología,
[2] Hospital San Pedro de Alcántara,undefined
[3] Avda. Pablo Naranjo s/n,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1082 / 1083
页数：1
相关论文
共 50 条
  • [11] CD20 aberrant expression of multiple myeloma
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 259 - 259
  • [12] Complement-mediated cytotoxicity of rituximab to CD20 positive myeloma cell line MC/CAR
    Umeda, M
    Kuraishi, Y
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 82P - 82P
  • [13] Maintenance therapy with rituximab (CD20 antibody) following autologous stem cell transplantation for multiple myeloma
    Georgievski, B
    Cevreska, L
    Ivanovski, M
    Siljanovski, N
    Stojanovik, A
    Karanfilski, O
    Stojanoski, Z
    Panovska, I
    Pivkova, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S81 - S81
  • [14] CD20 and Cyclin D1 expression in multiple myeloma
    Doghri, R.
    Tekari, F.
    Charfi, L.
    BoujelbSne, N.
    Abbes, I.
    Houcine, Y.
    Kamoun, S.
    Kcharem, N.
    Mrad, K.
    Driss, M.
    VIRCHOWS ARCHIV, 2017, 471 : S331 - S332
  • [15] Transient downmodulation of CD20 by rituximab.
    Jilani, I
    O'Brien, S
    Manshouri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    BLOOD, 2002, 100 (11) : 804A - 804A
  • [16] TO B OR NOT TO B: A CASE OF CD20 ANTIGEN EXPRESSION IN SYMPTOMATIC MULTIPLE MYELOMA
    Thim, Monica
    Khanna, Shrinkhala
    Sliwa, Donielle F.
    Oh, Sung-Hee
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S766 - S767
  • [17] Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121
    Taupin, Philippe
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (01) : 111 - 114
  • [18] Rebound of multiple sclerosis in patients treated with anti CD20 after discontinuation of rituximab
    Missione, Rosanna
    Signoriello, Elisabetta
    Bonavita, Simona
    Lus, Giacomo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [19] Regarding the loss of CD20 after rituximab therapy
    Lee, R
    Braylan, RC
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 118 (03) : 927 - 927
  • [20] STUDY ON THE PRONOTIC IMPACT OF CD117 IN PATIENTS WITH MULTIPLE MYELOMA (MM) CD20 POSITIVE. EXPERIENCE OF A SINGLE CENTER
    Moret Puig, C.
    Santos Carvajal, N. Y.
    Blanco Benigno, A.
    Tuset Andujar, E.
    Cruz Garcia, D.
    Lloveras Guelque, N.
    Coll Jorda, R.
    Guardia Sanchez, R.
    Roncero Vidal, J. M.
    Kelleher, N.
    Sagues Serrano, M.
    Diaz Santa, J.
    Mostacedo Marasovic, S.
    Bustins Tarrats, A.
    Buxo, M.
    Gallardo Giralt, D.
    Gonzalez Montes, Y.
    HAEMATOLOGICA, 2017, 102 : 305 - 306
12345